VA-REGULA
Access to international festivals like Sziget and Untold, which draw up to 100,000 visitors daily, has been significantly enhanced. Regula, a global developer of forensic devices and identity verification solutions, and Netpositive, a Hungarian IT service provider specializing in large-scale event management, joined forces to switch to mobile ID verification (IDV) via a special app empowered by IDV software. As a result, Netpositive’s state-of-the-art Backstage Ticketing ecosystem has become an even more valuable asset for event organizers across the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240604833546/en/
Netpositive’s new Backstage Ticketing solution for large events’ visitor ID verification based on Regula Document Reader SDK (Graphic: Business Wire)
The backbone of access services to large-scale events is the so-called “redemption” process, during which visitor tickets are checked and exchanged for wristbands with designated access rights. For this process to function properly, it is necessary to identify event visitors by their identity documents.
Netpositive used to handle document verification with the help of designated ID scanners provided by a third-party vendor. Apart from that, the company also employed a range of other devices, such as barcode readers, NFC readers, and laptops. The complexity of managing these devices often led to inefficiencies at event redemption points.
To make the process more productive and streamlined, Netpositive decided to switch to mobile ID verification (IDV) via a special app empowered by IDV software. After performing extensive research and following a partner’s recommendation, Netpositive opted for Regula Document Reader SDK, a comprehensive identity document verification software solution. Within one month, Regula’s solution was seamlessly built into Netpositive’s Backstage Ticketing Access Management App and integrated into their larger ecosystem, where they manage everything from ticket sales to redemption checks to event dashboards.
Regula Document Reader SDK allows Netpositive’s Backstage Ticketing ecosystem to read and verify passports, ID cards, and driver’s licenses with a single mobile device. Not only does Regula’s solution speed up the document check process, but it also enhances security by performing cross-checks to identify any data discrepancies that could indicate fraud. Apart from that, Regula Document Reader SDK re-verifies biometric documents on the server side in the customer’s secure perimeter in order to ensure that the chip is genuine and its data has not been cloned or manipulated, and thus prevent sophisticated fraud. The solution's extensive document template database includes over 13,900 templates from 249 countries and territories, ensuring comprehensive coverage and seamless processing for international event attendees.
Implementing Regula’s technology has already shown remarkable success at recent events, such as Untold Dubai, visited by over 185,000 people, and Massif in Romania, with a capacity of 12,000 people per day. The streamlined mobile solution has reduced queues, cut down manual labor, and received overwhelmingly positive feedback from staff and attendees alike.
In the long run, Netpositive expects to cut expenses on device procurement, and expects to significantly reduce the number of technical problems involved with the redemption process, which were relatively frequent with the previous solution.
“We are still at an early stage of the access admission process transformation, and we assume we will get more tangible results during the coming season of summer festivals. But we are very sure of one thing: with this new solution with the Regula Document Reader SDK at the core, we made a real innovation. The reinvention of the redemption process helped us become more competitive, promoting our position in the market,” says Mátyás Török, Netpositive’s founder and CEO.
"Our collaboration with Netpositive not only showcases the importance of robust and efficient identity verification, but also sets a new standard for access management in large-scale events. We are proud to contribute to creating safer and more efficient event experiences around the globe," says Ihar Kliashchou, Chief Technology Officer at Regula.
For more information on how Netpositive is transforming event access management with Regula’s IDV solutions, read the success story.
About Netpositive
Netpositive creates large-scale, unique, load-proof digital solutions. With more than 50 partners, 500 international events, and 36 million unique users, it became Central Europe's leading event IT service provider during the last 10 years. You can meet its staff and its self-developed Backstage Ticketing ecosystem at several domestic and international events, including award-winning music festivals like Sziget (HU) and Untold (RO).
Learn more at www.netpositive.hu.
About Regula
Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the largest library of document templates in the world, we create breakthrough technologies in document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security or speed. Regula was repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.
Learn more at www.regulaforensics.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240604833546/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press release
Ranks 125th Among 500 Companies Around the GlobeTop 10% in the Environmental Sector Among 3,000 Major Global Companies Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 10
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press release
Agreement Marks Significant Step Towards Increasing Italy’s Contribution to advancing Lunar Exploration ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom